Published in Lab Business Week, May 14th, 2006
The grant was submitted to the National Institutes of Health (NIH) to be directed to the National Institute of Allergy and Infectious Disease (NIAID) as a phase I Small Business Innovation Grant. The grant application discusses the deployment of the Aethlon Hemopurifier as a therapy to clear inflammatory cytokines, H5N1 Avian Flu virus and viral fragments that stimulate viral sepsis.
Grant collaborators include Leo L.M. Poon, Assistant professor at the University of Hong Kong, Department of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.